» Articles » PMID: 11838846

Systemic Lupus Erythematosus Disease Activity Index 2000

Overview
Journal J Rheumatol
Specialty Rheumatology
Date 2002 Feb 13
PMID 11838846
Citations 1292
Authors
Affiliations
Soon will be listed here.
Abstract

Objective: To describe the Systemic Lupus Erythematosus Disease Activity Index 2000 (SLEDAI-2K), a modification of SLEDAI to reflect persistent, active disease in those descriptors that had previously only considered new or recurrent occurrences, and to validate SLEDAI-2K against the original SLEDAI as a predictor for mortality and as a measure of global disease activity in the clinic.

Methods: All visits in our cohort of 960 patients were used to correlate SLEDAI-2K against the original SLEDAI, and the whole cohort was used to validate SLEDAI-2K as a predictor of mortality. A subgroup of 212 patients with SLE followed at the Lupus Clinic who had 5 regular visits, 3-6 months apart, in 1991-93 was also included. An uninvolved clinician evaluated each patient record and assigned a clinical activity level. The SLEDAI score was calculated from the database according to both the original and modified definitions.

Results: SLEDAI-2K correlated highly (r = 0.97) with SLEDAI. Both methods for SLEDAI scoring predicted mortality equally (p = 0.0001), and described similarly the range of disease activity as recognized by the clinician.

Conclusion: SLEDAI-2K, which allows for persistent activity in rash, mucous membranes, alopecia, and proteinuria, is suitable for use in clinical trials and studies of prognosis in SLE.

Citing Articles

Mycophenolic acid trough level assessment in patients with lupus nephritis; does it make a difference?.

Abdulgalil A, Elnagdy N, Ramadan N, Hamza E, Hammad A, Korkor M Pediatr Rheumatol Online J. 2025; 23(1):26.

PMID: 40075510 PMC: 11905544. DOI: 10.1186/s12969-025-01074-7.


Prediction of Flares in Systemic Lupus Erythematosus During Post-Remission Follow-up.

Bai Y, Zhao J, Wang Q, Xu D, Zeng X, Tian X J Inflamm Res. 2025; 18:3377-3384.

PMID: 40070926 PMC: 11895687. DOI: 10.2147/JIR.S504995.


The neutrophil-to-C3 ratio: unveiling diagnostic efficacy for lupus nephritis and association with reduced retinal vascular density in systemic lupus erythematosus.

Maitiyaer M, Li P, Li H, Jiang D, Zhang J, Yang C Front Pharmacol. 2025; 16:1484320.

PMID: 40046753 PMC: 11880234. DOI: 10.3389/fphar.2025.1484320.


Body weight in systemic lupus erythematosus is associated with disease activity and the adaptive immune system, independent of type I IFN.

Teruya H, Shoda H, Itamiya T, Tsuchida Y, Okamura T, Fujio K Front Immunol. 2025; 16:1503559.

PMID: 40040694 PMC: 11876045. DOI: 10.3389/fimmu.2025.1503559.


Blood gene expression of Toll-like receptors in SLE patients with lupus nephritis or neuropsychiatric systemic lupus erythematosus.

Dudkova M, Petrackova A, Radvansky M, Skacelova M, Videman J, Manakova J Arthritis Res Ther. 2025; 27(1):41.

PMID: 40011954 PMC: 11863772. DOI: 10.1186/s13075-025-03512-z.